PAIGE HOUSER: Open Payments
NPI 1356466627 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$912 in 36 payments from 10 companies in 2025. Trend: 2023 $1,893 · 2024 $1,343 · 2025 $912
Food & beverage: $912
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 17 | $359 |
| Neurocrine BioSciences, Inc. | 4 | $254 |
| Lundbeck LLC | 3 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| ABBVIE INC. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Novo Nordisk Inc | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: INGREZZA, HETLIOZ, FANAPT, REXULTI, SPRAVATO, ABILIFY ASIMTUFII, SKYRIZI, TRINTELLIX.
Industry payments across NC — which companies pay providers there.
